6-Thioguanine, >=98%
Application
6-Thioguanine has been used:to induce autophagy and apoptosis in colorectal cancer cell lines HCT116as a selection marker in the mutation and survival assay in chinese hamster lung fibroblasts culture V79as a selection marker in clonogenic Lung metastasis assay of 4T1-luc cells
Biochem/physiol Actions
Ribosylated and phosphorylated by the same pathway as natural purine bases; as the nucleotide, inhibits a variety of cellular processes involved in nucleic acid synthesis. Has a long history as an effective treatment of leukemia.
Antimetabolite used in the treatment of leukemias. Competes with hypoxanthine and guanine for the enzyme hypoxanthine-guanine phosphoribosyltransferase, which catalzyes a critical step in the generation of purine nucleotides.
General description
6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking. 6-Thioguanine usage in treating inflammatory bowel disease (IBD) contributes to nodular regenerative hyperplasia (NRH) in the liver.
Packaging
100, 250, 500 mg in glass bottle
1, 5 g in glass bottle
| Quality Level | 200 |
|---|---|
| mp | ≥300 °C (lit.) |
| InChI key | WYWHKKSPHMUBEB-UHFFFAOYSA-N |
| InChI | 1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11) |
| Manufacturer | SIGMA-ALDRICH |
| Form | powder |
| Assay | ≥98% |
There are no downloads for this product.
